4.3 Article

CROWNED DENS SYNDROME: REPORT OF THREE CASES AND A REVIEW OF THE LITERATURE

Journal

JOURNAL OF EMERGENCY MEDICINE
Volume 49, Issue 1, Pages E9-E13

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jemermed.2015.02.005

Keywords

pseudogout; neck pain; calcification; computed tomography

Ask authors/readers for more resources

Background: Patients with crowned dens syndrome (CDS), which is pseudogout of the atlantoaxial junction induced by crown-like calcifications around the dens, present with symptoms of severe neck pain, rigidity, and high fever. CDS patients are often misdiagnosed as having meningitis or polymyalgia rheumatica, leading to potentially unnecessary invasive procedures for diagnosis and treatment. Case Report: We report 3 patients with CDS who had characteristic findings on computed tomography (CT), all of whom quickly recovered with nonsteroidal anti-inflammatory drug (NSAID) administration. In addition, we reviewed 72 published cases, including our patients. CDS typically occurs in elderly people (mean age 71.4 years). Common symptoms include neck pain (100%), neck rigidity (98%), and fever (80.4%), and most show elevated inflammatory markers (88.3%) on serum laboratory tests. Neck pain on rotation is a characteristic and helpful symptom in the diagnosis. The most useful modality is CT (97.1%), showing linear calcium deposits around the dens, mostly in the transverse ligament of atlas (TLA). CT number is especially helpful to distinguish a normal TLA (35-110 HU) from a calcified one (202-258 HU) in our cases. The most effective treatment is NSAID administration (85%), which usually leads to marked resolution of symptoms within days or weeks. Why Should an Emergency Physician Be Aware of This?: Due to acute and severe symptoms, CDS patients often present to an emergency department. To avoid unnecessary invasive procedures for diagnosis and treatment, CDS should be considered in the differential diagnosis of febrile neck pain. (C) 2015 Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Microbiology

Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease

Nadine Fornelos, Eric A. Franzosa, Jason Bishai, John W. Annand, Akihiko Oka, Jason Lloyd-Price, Timothy D. Arthur, Ashley Garner, Julian Avila-Pacheco, Henry J. Haiser, Andrew C. Tolonen, Jeffrey A. Porter, Clary B. Clish, R. Balfour Sartor, Curtis Huttenhower, Hera Vlamakis, Ramnik J. Xavier

NATURE MICROBIOLOGY (2020)

Article Gastroenterology & Hepatology

Prevalence of functional dyspepsia-like symptoms in ulcerative colitis patients in clinical remission and overlap with irritable bowel syndrome-like symptoms

Satoshi Kotani, Nobuhiko Fukuba, Kousaku Kawashima, Yoshiyuki Mishima, Hiroki Sonoyama, Eiko Okimoto, Yasumasa Tada, Akihiko Oka, Yuji Tamagawa, Naoki Oshima, Tsuyoshi Mishiro, Hiroshi Tobita, Kotaro Shibagaki, Ichiro Moriyama, Norihisa Ishimura, Yoshinori Kushiyama, Hirofumi Fujishiro, Shunji Ishihara

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2020)

Article Gastroenterology & Hepatology

Dietary Fructose Alters the Composition, Localization, and Metabolism of Gut Microbiota in Association With Worsening Colitis

David C. Montrose, Ryohei Nishiguchi, Srijani Basu, Hannah A. Staab, Xi Kathy Zhou, Hanhan Wang, Lingsong Meng, Melanie Johncilla, Juan R. Cubillos-Ruiz, Diana K. Morales, Martin T. Wells, Kenneth W. Simpson, Shiying Zhang, Belgin Dogan, Chen Jiao, Zhangjun Fei, Akihiko Oka, Jeremy W. Herzog, R. Balfour Sartor, Andrew J. Dannenberg

Summary: Excessive dietary fructose consumption exacerbates colitis by altering the composition, distribution, and metabolic function of resident enteric microbiota, leading to increased access of gut luminal microbes to the colonic mucosa, reduced protective commensal microbes, and increased luminal conjugated bile acids, all of which worsen colitis.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Nutrition & Dietetics

Comparison of dapagliflozin and teneligliptin in nonalcoholic fatty liver disease patients without type 2 diabetes mellitus: a prospective randomized study

Hiroshi Tobita, Tomotaka Yazaki, Masatoshi Kataoka, Satoshi Kotani, Akihiko Oka, Tsuyoshi Mishiro, Naoki Oshima, Kousaku Kawashima, Norihisa Ishimura, Kohji Naora, Shuichi Sato, Shunji Ishihara

Summary: The efficacy of SGLT2i and DPP4i in NAFLD patients without type 2 diabetes mellitus has not been previously reported. This study found that both dapagliflozin and teneligliptin treatment significantly reduced serum ALT levels in these patients, with dapagliflozin specifically leading to weight loss related to changes in body water and fat mass.

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2021)

Article Multidisciplinary Sciences

Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis

Daniel van der Lelie, Akihiko Oka, Safiyh Taghavi, Junji Umeno, Ting-Jia Fan, Katherine E. Merrell, Sarah D. Watson, Lisa Ouellette, Bo Liu, Muyiwa Awoniyi, Yunjia Lai, Liang Chi, Kun Lu, Christopher S. Henry, R. Balfour Sartor

Summary: Environmental factors, mucosal permeability, and defective immunoregulation contribute to overactive immunity towards certain intestinal bacteria, leading to various inflammatory conditions. GUT-108 expands beneficial gut bacteria, reduces pathogens, promotes mucosal healing and immune regulation.

NATURE COMMUNICATIONS (2021)

Review Medicine, General & Internal

A New Dawn for the Use of Artificial Intelligence in Gastroenterology, Hepatology and Pancreatology

Akihiko Oka, Norihisa Ishimura, Shunji Ishihara

Summary: Artificial intelligence (AI) is rapidly becoming a crucial tool in the medical field, especially in early cancer detection and precision medicine. This review focuses on the applications of AI technology in gastroenterology, hepatology, and pancreatology.

DIAGNOSTICS (2021)

Article Medicine, General & Internal

The Simultaneous Onset of Pancreatitis and Colitis as Immune-related Adverse Events in a Patient Receiving Nivolumab Treatment for Renal Cell Carcinoma

Tomotaka Yazaki, Ichiro Moriyama, Hiroshi Tobita, Hiroki Sonoyama, Eiko Okimoto, Akihiko Oka, Yoshiyuki Mishima, Naoki Oshima, Kotaro Shibagaki, Kousaku Kawashima, Norihisa Ishimura, Taichi Nagami, Riruke Maruyama, Hiroaki Shiina, Shunji Ishihara

Summary: Immune checkpoint inhibitors (ICIs) have anti-tumor effects but can also result in a variety of immune-related adverse events (irAEs). This rare case report describes a patient with renal cell carcinoma who developed acute pancreatitis and colitis simultaneously as irAEs during nivolumab treatment, and showed significant improvement with corticosteroid therapy.

INTERNAL MEDICINE (2022)

Article Nutrition & Dietetics

The Emulsifier Carboxymethylcellulose Induces More Aggressive Colitis in Humanized Mice with Inflammatory Bowel Disease Microbiota Than Polysorbate-80

Esmat Rousta, Akihiko Oka, Bo Liu, Jeremy Herzog, Aadra P. Bhatt, Jeremy Wang, Mohammad B. Habibi Najafi, Ryan Balfour Sartor

Summary: The study found that commonly used synthetic dietary emulsifiers have different effects on intestinal inflammation: CMC exacerbates inflammation, while P80 affects specific microbiota populations.

NUTRIENTS (2021)

Article Gastroenterology & Hepatology

Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission

Kousaku Kawashima, Naoki Oshima, Kenichi Kishimoto, Masatoshi Kataoka, Mai Fukunaga, Satoshi Kotani, Hiroki Sonoyama, Akihiko Oka, Yoshiyuki Mishima, Hideaki Kazumori, Noriyoshi Ishikawa, Asuka Araki, Shunji Ishihara

Summary: This study aimed to determine the optimal FC cutoff value for predicting HH in UC patients and investigate FC's predictability for prolonged CR. The results showed that FC levels < 82 μg/g can predict HH in UC patients with clinical and endoscopic remission, and low FC also leads to prolonged CR.

INFLAMMATORY BOWEL DISEASES (2023)

Article Pathology

KLF4 Mutation Shapes Pathologic Characteristics of Foveolar-Type Gastric Adenoma in Helicobacter pylori-Naive Patients

Tsuyoshi Mishiro, Kotaro Shibagaki, Chika Fukuyama, Masatoshi Kataoka, Takumi Notsu, Noritsugu Yamashita, Akihiko Oka, Mamiko Nagase, Asuka Araki, Kousaku Kawashima, Norihisa Ishimura, Riruke Maruyama, Yoshikazu Kinoshita, Shunji Ishihara

Summary: With the decrease in Helicobacter pylori-infected individuals, the occurrence of gastric neoplasms in H. pylori-naive patients, such as sporadic foveolar-type gastric adenoma (FGA), has been increasing. This study investigated the genomic features of sporadic FGA and identified a novel single-nucleotide variation (SNV) in the KLF4 gene that may contribute to the slow-growing properties of this neoplasm.

AMERICAN JOURNAL OF PATHOLOGY (2022)

Article Biochemistry & Molecular Biology

Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation

Sara Federici, Sharon Kredo-Russo, Rafael Valdes-Mas, Denise Kviatcovsky, Eyal Weinstock, Yulia Matiuhin, Yael Silberberg, Koji Atarashi, Munehiro Furuichi, Akihiko Oka, Bo Liu, Morine Fibelman, Iddo Nadav Weiner, Efrat Khabra, Nyssa Cullin, Noa Ben-Yishai, Dana Inbar, Hava Ben-David, Julian Nicenboim, Noga Kowalsman, Wolfgang Lieb, Edith Kario, Tal Cohen, Yael Friedman Geffen, Lior Zelcbuch, Ariel Cohen, Urania Rappo, Inbar Gahali-Sass, Myriam Golembo, Vered Lev, Mally Dori-Bachash, Hagit Shapiro, Claudia Moresi, Amanda Cuevas-Sierra, Gayatree Mohapatra, Lara Kern, Danping Zheng, Samuel Philip Nobs, Jotham Suez, Noa Stettner, Alon Harmelin, Naomi Zak, Sailaja Puttagunta, Merav Bassan, Kenya Honda, Harry Sokol, Corinna Bang, Andre Franke, Christoph Schramm, Nitsan Maharshak, Ryan Balfour Sartor, Rotem Sorek, Eran Elinav

Summary: A clade of Klebsiella pneumoniae strains has been found to be strongly associated with exacerbation and severity of inflammatory bowel diseases. By generating a lytic five-phage combination targeting these strains, effective suppression of the bacteria and attenuation of inflammation can be achieved.
Article Microbiology

Impact of a phage cocktail targeting Escherichia coli and Enterococcus faecalis as members of a gut bacterial consortium in vitro and in vivo

Colin Buttimer, Tom Sutton, Joan Colom, Ellen Murray, Pedro H. Bettio, Linda Smith, Andrei S. Bolocan, Andrey Shkoporov, Akihiko Oka, Bo Liu, Jeremy W. Herzog, R. Balfour Sartor, Lorraine A. Draper, R. Paul Ross, Colin Hill

Summary: The study found that while phages can effectively reduce the population of host bacteria in in vitro models, this effect did not translate to a similar outcome in in vivo settings. This is likely due to a reduction in phage numbers during transit of the mouse GIT.

FRONTIERS IN MICROBIOLOGY (2022)

Article Gastroenterology & Hepatology

Real-world efficacy and safety of advanced therapies in hospitalized patients with ulcerative colitis

Makoto Naganuma, Taku Kobayashi, Reiko Kunisaki, Katsuyoshi Matsuoka, Shojiro Yamamoto, Ami Kawamoto, Daisuke Saito, Kosaku Nanki, Kazuyuki Narimatsu, Hisashi Shiga, Motohiro Esaki, Shinichiro Yoshioka, Shingo Kato, Masayuki Saruta, Shinji Tanaka, Eriko Yasutomi, Kaoru Yokoyama, Kei Moriya, Yoshikazu Tsuzuki, Makoto Ooi, Mikihiro Fujiya, Atsushi Nakazawa, Takayuki Abe, Tadakazu Hisamatsu, Japanese UC Study Grp

Summary: Most first-use advanced therapies were effective for patients with acute severe ulcerative colitis, while second-use advanced therapies might have had limited benefits in inducing clinical remission. These findings may provide insights for the management of hospitalized patients.

JOURNAL OF GASTROENTEROLOGY (2023)

Meeting Abstract Gastroenterology & Hepatology

MUCOSAL METABOLITES FUEL THE GROWTH AND VIRULENCE OF E. COLI LINKED TO CROHN'S DISEASE

Shiying Zhang, Xochitl Morgan, Belgin Dogan, Francois-Pierre J. Martin, Suzy Strickler, Akihiko Oka, Jeremy Herzog, Bo Liu, Scot E. Dowd, Curtis Huttenhower, Matthieu Pichaud, Esra Dogan, Randy Longman, Rhonda Yantiss, Lukas A. Mueller, Ellen J. Scherl, R. Balfour Sartor, Kenneth W. Simpson

GASTROENTEROLOGY (2022)

Article Nutrition & Dietetics

Long-lasting renal dysfunction following tacrolimus induction therapy in ulcerative colitis patients

Na Cha, Naoki Oshima, Kenichi Kishimoto, Satoshi Kotani, Eiko Okimoto, Tomotaka Yazaki, Hiroki Sonoyama, Akihiko Oka, Yoshiyuki Mishima, Kotaro Shibagaki, Hiroshi Tobita, Kousaku Kawashima, Norihisa Ishimura, Shunji Ishihara

Summary: This study examined the impact of oral tacrolimus (TAC) on renal function in patients with ulcerative colitis (UC) undergoing remission induction therapy. The results showed that although TAC was effective in inducing remission in both elderly and non-elderly patients, a decline in estimated glomerular filtration rate (eGFR) was observed in almost all patients, with a maximum change of -34.4% from baseline at week 11. The decline in eGFR recovered quickly after TAC discontinuation, but did not return to baseline at two years following cessation of treatment. Age and peak serum trough level during TAC treatment significantly influenced the rate of eGFR change. Elderly patients experienced a greater decline in eGFR compared to non-elderly patients, and the difference in eGFR decline rate persisted at two years after treatment withdrawal. Therefore, careful monitoring of renal function and close attention to eGFR changes are important in UC patients receiving oral TAC, particularly in elderly patients after treatment cessation.

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2022)

No Data Available